NCT06979466 (EMAGINE-C) is a NA clinical trial of Q Therapeutic System (BQ 3.0) - Active in Stroke, sponsored by Burke Rehabilitation Hospital.

Who is sponsoring NCT06979466?

NCT06979466 is sponsored by Burke Rehabilitation Hospital.

What drugs are being tested in NCT06979466?

Interventions in NCT06979466: Q Therapeutic System (BQ 3.0) - Active.

What condition does NCT06979466 study?

NCT06979466 studies Stroke, Hemorrhage, Brain Injury, Cerebrovascular Accident (CVA), Chronic Stroke Patient.

Is NCT06979466 still recruiting?

NCT06979466 is currently recruiting now. Last updated 12 August 2025.

Last reviewed 2025-08-12 · How we verify

NCT06979466: EMAGINE-C

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Q Therapeutic System for Chronic Stroke Recovery

Recruiting now NA Last updated 12 August 2025

What this trial tests

NA trial testing Q Therapeutic System (BQ 3.0) - Active in Stroke in 25 participants. Currently enrolling.

Timeline

26 May 2025

Primary endpoint
31 May 2026

30 June 2026

Quick facts

Lead sponsor	Burke Rehabilitation Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	26 May 2025
Primary completion	31 May 2026
Estimated completion	30 June 2026
Sites	1 location across United States

Drugs / interventions tested

Q Therapeutic System (BQ 3.0) - Active

Conditions studied

Stroke — all drugs for Stroke →
Hemorrhage — all drugs for Hemorrhage →
Brain Injury — all drugs for Brain Injury →
Cerebrovascular Accident (CVA) — all drugs for Cerebrovascular Accident (CVA) →

Sponsor

Burke Rehabilitation Hospital

Who can join

Adults 18 to 80, any sex, with Stroke or Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the effectiveness of the Q Therapeutic (BQ 3.0) System for individuals with chronic stroke in improving upper extremity function as determined by change in functional outcome measures after 3-month treatment, including in-clinic and at-home sessions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06979466 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Burke Rehabilitation Hospital
Last refreshed: 12 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06979466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing